Neuroathletic Training in Adolescent Basketball Players
6 maj 2026 uppdaterad av: Gizem Gül, Pamukkale University
Effects of Neuroathletic Training on Dynamic Visual Acuity, Endurance, Balance, Kinesiophobia, and Injury Risk in Adolescent Basketball Players: A Randomized Controlled Trial
This randomized controlled study aims to investigate the effects of neuroathletic training on dynamic visual acuity, endurance, balance, and injury risk in adolescent basketball players.
Licensed basketball players aged 14-17 years will be randomly assigned to either a neuroathletic training group or a control group.
The training group will receive sport-specific progressive neuroathletic exercises in addition to their regular basketball training for one week, while the control group will continue their usual training routine.
Before and after the intervention, participants will be assessed for dynamic visual acuity, core muscle endurance, balance, functional movement, pain, and kinesiophobia.
The findings of this study may help clarify whether neuroathletic training can improve performance-related outcomes and reduce injury risk in adolescent basketball players.
Studieöversikt
Status
Avslutad
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
30
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Pamukkale/Kınıklı
-
Denizli, Pamukkale/Kınıklı, Turkiet (Türkiye), 20070
- Pamukkale University
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
Tar emot friska volontärer
Ja
Beskrivning
Inclusion Criteria:
Aged between 14 and 17 years, Being a professional or amateur basketball player, Participating in sports for at least five hours per week and having engaged in the sport for a minimum of two years, Having no cognitive or motor dysfunction, Providing written informed consent signed by the parents/legal guardians.
Exclusion Criteria:
Reporting a back or lower extremity injury within the previous six months, Having any relevant medical history or current condition that could affect the balance system or perception-action system (e.g., neurological disorders, inner ear disorders, or color blindness), Using medications or substances that could affect balance and visual-motor reaction time performance.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Kontrollgrupp
|
|
|
Experimentell: Neuroathletisk Träningsgrupp
|
This intervention is a progressive neuroathletic training program developed by the research team to improve motor skills, balance, eye coordination, and vestibular function in adolescent basketball players.
The program is performed for approximately 20 minutes per day over 6 days and includes visual relaxation exercises, eye massage, unilateral vertical jumping, Brock string training, shoulder/wrist/ankle circular movements, sacculus activation, cerebellar activation, and antisaccade exercises.
The content is progressively advanced across days by integrating balance challenges and visual-vestibular tasks.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Functional Movement Screen (FMS) total score
Tidsram: Baseline and immediately following the 1-week intervention
|
Assessment of injury risk and movement quality using the Functional Movement Screen total score.
The test consists of 7 movement patterns scored from 0 to 3, with higher scores indicating better functional movement quality and lower injury risk.
|
Baseline and immediately following the 1-week intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Dynamic Visual Acuity (DVA)
Tidsram: Baseline and immediately following the 1-week intervention
|
Dynamic visual acuity assessed using a visual chart while the participant performs active horizontal head movements.
The lowest clearly read line will be recorded.
|
Baseline and immediately following the 1-week intervention
|
|
Balance Error Scoring System (BESS) / Denge Hata Puanlama Sistemi
Tidsram: Baseline and immediately following the 1-week intervention
|
Postural stability assessed by the number of balance errors performed in double-leg, single-leg, and tandem stance conditions.
Lower scores indicate better balance performance.
|
Baseline and immediately following the 1-week intervention
|
|
Core muscle endurance (Prone plank test)
Tidsram: Baseline and immediately following the 1-week intervention
|
Core endurance assessed by the duration the participant maintains the correct prone plank position.
Longer duration indicates better core endurance.
|
Baseline and immediately following the 1-week intervention
|
|
Tampa Scale for Kinesiophobia (TSK)
Tidsram: Baseline and immediately following the 1-week intervention
|
Kinesiophobia assessed using the Tampa Scale for Kinesiophobia.
Higher scores indicate greater fear of movement.
|
Baseline and immediately following the 1-week intervention
|
|
Visual Analog Scale (VAS) for pain
Tidsram: Baseline and immediately following the 1-week intervention
|
Pain intensity assessed using a 100-mm visual analog scale, with higher scores indicating greater pain intensity.
|
Baseline and immediately following the 1-week intervention
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
15 februari 2025
Primärt slutförande (Faktisk)
26 oktober 2025
Avslutad studie (Faktisk)
12 januari 2026
Studieregistreringsdatum
Först inskickad
29 april 2026
Först inskickad som uppfyllde QC-kriterierna
6 maj 2026
Första postat (Faktisk)
13 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
13 maj 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
6 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- PAU-FTR-GG-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .